Citation: Hm. Dodds et al., Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance, CANC CHEMOT, 45(1), 2000, pp. 9-14
Citation: Hm. Dodds et al., More about: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin, J NAT CANC, 91(1), 1999, pp. 91-92
Citation: Hm. Dodds et Lp. Rivory, The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11), MOLEC PHARM, 56(6), 1999, pp. 1346-1353